Fiche centre
The First Hospital of Shanxi Medical University
Taiyuan — China
Essais liés3clinical trials
VilleTaiyuanlocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07732309
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Cizutamig | Myasthénie | Phase 1 | NCT07215650 | Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG) | RECRUITING |
| Rimegepant | Migraine | Phase 3 | NCT05810038 | A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects. | COMPLETED |
| ATG-201 | Lupus | Phase 1 | NCT07732309 | ATTRACT — A Study of ATG-201 in Adult Participants With Autoimmune Diseases | NOT_YET_RECRUITING |